Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mesothelioma, Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02004028
What this trial is testing

Window of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma Participants

Who this might be right for
Malignant Pleural Mesothelioma
Verastem, Inc. 35
Early research (Phase 1)Study completedNCT05071014
What this trial is testing

Pembrolizumab and Cryoablation in People With Mesothelioma

Who this might be right for
Lung CancerUnresectable Mesothelioma
Memorial Sloan Kettering Cancer Center 2
Large-scale testing (Phase 3)Study completedNCT02349412
What this trial is testing

Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers

Who this might be right for
Liver CancerAnxiety DisorderDepression+7 more
Alliance for Clinical Trials in Oncology 405
Early research (Phase 1)Study completedNCT02798536
What this trial is testing

Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant Mesothelioma

Who this might be right for
Mesothelioma
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT03007030
What this trial is testing

Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery

Who this might be right for
CD30-Positive Neoplastic Cells PresentMalignant Mesothelioma
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Ended earlyNCT00165503
What this trial is testing

Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate

Who this might be right for
Pleural MesotheliomaMalignant Pleural Mesothelioma
Dana-Farber Cancer Institute 16
Early research (Phase 1)Study completedNCT01212367
What this trial is testing

Intrapleural Gene Transfer for Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Abramson Cancer Center at Penn Medicine 13
Testing effectiveness (Phase 2)Study completedNCT04480372
What this trial is testing

SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II

Who this might be right for
Malignant Pleural MesotheliomaNon-small Cell Lung Cancer
Swiss Cancer Institute 68
Testing effectiveness (Phase 2)Ended earlyNCT00859495
What this trial is testing

Trimodal Lung-Sparing Treatment of Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma
Columbia University 9
Testing effectiveness (Phase 2)Study completedNCT00458913
What this trial is testing

Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC 82
Early research (Phase 1)Study completedNCT01655225
What this trial is testing

LY3023414 in Participants With Advanced Cancer

Who this might be right for
Advanced CancerMetastatic CancerNon-Hodgkin's Lymphoma+3 more
Eli Lilly and Company 156
Early research (Phase 1)Study completedNCT04316689
What this trial is testing

First-in-human Study of S-588210 (S-488210+S-488211)

Who this might be right for
Lung CancerHead and Neck CancerBladder Cancer+2 more
Shionogi 10
Not applicableStudy completedNCT02585362
What this trial is testing

Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program

Who this might be right for
Lung CancerGastro-Intestinal CancerBreast Cancer+5 more
Kantonsspital Winterthur KSW 52
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Testing effectiveness (Phase 2)UnknownNCT01569919
What this trial is testing

A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma

Who this might be right for
MalignantPleuralMesothelioma
Wales Cancer Trials Unit 26
Testing effectiveness (Phase 2)Study completedNCT00154388
What this trial is testing

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Who this might be right for
Life Threatening Diseases
Novartis Pharmaceuticals 185
Testing effectiveness (Phase 2)Study completedNCT02875548
What this trial is testing

Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma (FL)Synovial Sarcoma+5 more
Epizyme, Inc. 58
Early research (Phase 1)Active Not RecruitingNCT04491942
What this trial is testing

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Who this might be right for
Advanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more
National Cancer Institute (NCI) 74
Early research (Phase 1)Active Not RecruitingNCT05238883
What this trial is testing

HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

Who this might be right for
Gastric CancerRenal Cell CarcinomaMelanoma+6 more
HiFiBiO Therapeutics 72
Early research (Phase 1)Looking for participantsNCT06196294
What this trial is testing

GPC3/Mesothelin-CAR-γδT Cells Against Cancers

Who this might be right for
Pancreas CancerLung CancerLiver Cancer+3 more
Second Affiliated Hospital of Guangzhou Medical University 30
Next Page